Akzo Nobel's new business Nobilon has started operating
Nobilon will develop, produce and market human vaccines -- Diosynth, Intervet and Oregon are expected to give support
09-Jul-2003 -
A new biotech company set up by Akzo Nobel to develop, produce and market human vaccines has started operating in a state-of-the facility located in the Netherlands.
Nobilon will call upon the expertise of the company's three pharmaceutical businesses-Diosynth, Intervet and Organon-with plans to ...
active pharmaceutical ingredients
Netherlands
vaccines